Live feed
Filing
SC 13D
SC 13D0001072613-16-000849·Cascadian Therapeutics, Inc.
Schedule 13D ownership disclosure
Oncothyreon Inc.
Security class unavailable · CUSIP: 682324108
Event date: 2016-06-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000849
- Form type
- SC 13D
- Filer
- Cascadian Therapeutics, Inc.
- CIK
- CIK 1412067
- Filed
- Jul 11, 2016
- Reporting period
- Jun 28, 2016
- Description
- Schedule 13D beneficial ownership